REMEDIES moves on to next stage

Crystec are working in partnership with 22 organisations as part of the AMSCI ReMediES consortium, providing supercritical fluid (SCF) technology solutions to optimise the pharmaceutical supply chain.

Crystec form part of the Advanced Manufacturing Supply Chain Initiative (AMSCI) ReMediES consortium, a project that has been awarded £11.2m of government funding. The overall aim of the consortium is to address the inefficiencies in the pharmaceutical supply chain and involves 22 organisations ranging from Universities to SMEs and large multinationals. Crystec are leading the supercritical fluid technology application and are working closely with partner organisations to exploit the capability of the technology with a focus on reducing complexity, streamlining the supply chain, improving product quality and its fit for purpose. 

The full press release can be found here http://remediesproject.com/2015/08/27/remedies-moves-on-to-next-stage/. 

To keep up to date with the latest news from Crystec, please follow us on LinkedIn.